PRAX logo

Praxis Precision Medicines, Inc. Common Stock

PRAX

PRAX: Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.

more

Show PRAX Financials

Chart and Financial Data provided by TradingView

All
Government
Consumer Interest
SEC Filings
ESG/Other
Congress Trading

Recent trades of PRAX by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by PRAX's directors and management

Corporate Lobbying

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: 3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyridine as an ion channel modulator Aug. 22, 2023
  • Patent Title: 3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyridine as an ion channel modulator Aug. 22, 2023
  • Patent Title: Compounds and their methods of use Aug. 22, 2023
  • Patent Title: Hemi-citrate salts of gaba-a positive allosteric modulator and crystalline form thereof Jul. 11, 2023
  • Patent Title: Formulations of t-type calcium channel modulators and methods of use thereof May. 16, 2023
  • Patent Title: Substituted [1,2,4]triazolo[4,3-a]pyrazines as modulators of sodium channel activity Apr. 18, 2023
  • Patent Title: Substituted pyridines as ion channel modulators Nov. 22, 2022
  • Patent Title: Compounds and their methods of use Nov. 08, 2022
  • Patent Title: Formulations of t-type calcium channel modulators and methods of use thereof Aug. 30, 2022
  • Patent Title: Ion channel modulators Mar. 22, 2022
  • Patent Title: Compounds and their methods of use Mar. 22, 2022
  • Patent Title: Fused heteroaryl compounds, and methods thereof for treating diseases, disorders, and conditions relating to aberrant function of a sodium channel Mar. 01, 2022
  • Patent Title: 3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyrazine as an ion channel modulator May. 25, 2021
  • Patent Title: Salts and crystal forms of gaba Feb. 23, 2021
  • Patent Title: Salts and crystal forms of gaba Feb. 18, 2020
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of PRAX in WallStreetBets Daily Discussion

PRAX News

Recent insights relating to PRAX

CNBC Recommendations

Recent picks made for PRAX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in PRAX

Corporate Flights

Flights by private jets registered to PRAX